The Daily Pennsylvanian

Penn Medicine, CHOP to begin testing specialized gene therapy after working on new FDA protocol

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

Penn and CHOP will test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...
ascopubs.org

Institutional Scientific Review of Cancer Clinical Research Protocols: A Unique Requirement That Affects Activation Timelines

The National Cancer Institute (NCI) requirement that clinical trials at NCI-designated cancer centers undergo institutional scientific review in addition to institutional review board evaluation is ...

Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with ...
EurekAlert!

Largest international effort to improve mental health and wellbeing of health professionals and patient safety

LEUVEN, BELGIUM and PHILADELPHIA, PENNSYLVANIA, USA (August 1, 2022) – Magnet4Europe, a 4 million Euro project funded by the European Commission, is the largest international implementation science ...